| Name | Zee Care Inc |
|---|---|
| Organization Name | Zee Care Inc |
| Location | 873 Route 45, Ste 205, New City, New York 10956 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (877) 263-2631 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The New York Times reports that last week's action at the Supreme Court gave the public an in-depth view of the insitution and the justices. Meanwhile, the Associated Press reports that, in a recent speech, Justice Sonia Sotomayor didn't give any hints about what the high court will do on the health law question.
New research from Arizona State University, USA, uses a novel mathematical model to predict the impact of vaccination and vaccine-induced cross-protection on the B.1.1.7 variant and other SARS-CoV-2 variants circulating in the US as of June 2021. The study has been published in medRxiv* preprint server, while it undergoes peer review.
Novo Nordisk announced today that the U.S. Food and Drug Administration has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making the hemophilia A or B with inhibitors treatment available in 1, 2, 5 and 8 mg vials. The 8 mg vial allows a rapid initiation and administration of this medication for those patients who need a larger dose. In addition, FDA has also approved the extension of shelf life for all vial sizes from 24 months to 36 months at room temperature (at or below 77 degrees Fahrenheit).
Training surgeons with computer-based "surgery simulators" may create better surgeons and safer surgeries, according to a new study by NewYork-Presbyterian Hospital.
Hygeia Therapeutics, Inc. announced today the successful completion of a series of preclinical studies for HYG-102, their lead product for the treatment of vulvar and vaginal atrophy (VVA) and age-related skin fragility. HYG-102 is the lead biodegradable estrogenic candidate in a portfolio of 23 similar compounds licensed from the laboratory of Dr. Richard Hochberg of Yale University.
› Verified 8 days ago
| NPI Number | 1831708163 |
| Organization Name | ZEE CARE INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 873 Route 45 Ste 111, New City, NY 10956 |
| Phone Number | 877-263-2631 |
News Archive
The New York Times reports that last week's action at the Supreme Court gave the public an in-depth view of the insitution and the justices. Meanwhile, the Associated Press reports that, in a recent speech, Justice Sonia Sotomayor didn't give any hints about what the high court will do on the health law question.
New research from Arizona State University, USA, uses a novel mathematical model to predict the impact of vaccination and vaccine-induced cross-protection on the B.1.1.7 variant and other SARS-CoV-2 variants circulating in the US as of June 2021. The study has been published in medRxiv* preprint server, while it undergoes peer review.
Novo Nordisk announced today that the U.S. Food and Drug Administration has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making the hemophilia A or B with inhibitors treatment available in 1, 2, 5 and 8 mg vials. The 8 mg vial allows a rapid initiation and administration of this medication for those patients who need a larger dose. In addition, FDA has also approved the extension of shelf life for all vial sizes from 24 months to 36 months at room temperature (at or below 77 degrees Fahrenheit).
Training surgeons with computer-based "surgery simulators" may create better surgeons and safer surgeries, according to a new study by NewYork-Presbyterian Hospital.
Hygeia Therapeutics, Inc. announced today the successful completion of a series of preclinical studies for HYG-102, their lead product for the treatment of vulvar and vaginal atrophy (VVA) and age-related skin fragility. HYG-102 is the lead biodegradable estrogenic candidate in a portfolio of 23 similar compounds licensed from the laboratory of Dr. Richard Hochberg of Yale University.
› Verified 8 days ago
News Archive
The New York Times reports that last week's action at the Supreme Court gave the public an in-depth view of the insitution and the justices. Meanwhile, the Associated Press reports that, in a recent speech, Justice Sonia Sotomayor didn't give any hints about what the high court will do on the health law question.
New research from Arizona State University, USA, uses a novel mathematical model to predict the impact of vaccination and vaccine-induced cross-protection on the B.1.1.7 variant and other SARS-CoV-2 variants circulating in the US as of June 2021. The study has been published in medRxiv* preprint server, while it undergoes peer review.
Novo Nordisk announced today that the U.S. Food and Drug Administration has approved NovoSeven® RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) in an 8 mg vial size, making the hemophilia A or B with inhibitors treatment available in 1, 2, 5 and 8 mg vials. The 8 mg vial allows a rapid initiation and administration of this medication for those patients who need a larger dose. In addition, FDA has also approved the extension of shelf life for all vial sizes from 24 months to 36 months at room temperature (at or below 77 degrees Fahrenheit).
Training surgeons with computer-based "surgery simulators" may create better surgeons and safer surgeries, according to a new study by NewYork-Presbyterian Hospital.
Hygeia Therapeutics, Inc. announced today the successful completion of a series of preclinical studies for HYG-102, their lead product for the treatment of vulvar and vaginal atrophy (VVA) and age-related skin fragility. HYG-102 is the lead biodegradable estrogenic candidate in a portfolio of 23 similar compounds licensed from the laboratory of Dr. Richard Hochberg of Yale University.
› Verified 8 days ago
Zee Care Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 873 Route 45, New City, New York 10956 Phone: (877) 263-2631 | |
Cvs Pharmacy 01030 Type: Pharmacy Location: 280 S Main St, New City, New York 10956 Phone: (845) 639-8150 | |
Shop Rite Pharmacy Dept Type: Medicare Supplier Location: 66n Main St, New City, New York 10956 Phone: (845) 638-3218 | |
Walgreens #13468 Type: Community/Retail Pharmacy Location: 31 Cavalry Dr, New City, New York 10956 Phone: (845) 634-3341 | |
New City Pharmacy Type: DME Supplier - Customized Equipment Location: 174 S Main St, New City, New York 10956 Phone: (845) 407-0005 |